TXG Genomics (NASDAQ: TXG) Serge Saxonov lists recent Class A sales in Form 144

BioPharma DiveFDA delays decision on AstraZeneca breast cancer pill

FierceBiotechKordata Dynamics launches with neural-focused AI clinical trial model

Clinical OMICsDual CA19-9 Threshold Improves Risk Stratification in Pancreatic Cancer

Clinical OMICsCD169-Positive Macrophages Attacking Melanoma Imaged in Living Tissue

Clinical OMICsGuardant Nabs Key ACS Nod and Liquid Biopsy Approval

Clinical OMICsAI Foundation Model Maps Tumor Mutations to Predict Cancer Therapy Response

BioPharma DiveCardio drugmaker Kardigan plans to go public

BioPharma DiveKailera’s three-pronged obesity shot shows promise in early trial

BioPharma DiveApogee eczema drugs gets Blackstone backing, heads to Phase 3

Endpoints NewsAstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Wave

Endpoints NewsApogee secures Blackstone capital to move Dupixent rival into Phase 3

Clinical OMICsPrecancerous Adenomas Alter Gut Microbiome for Long Period